As reported by Reuters, the European Union is set to change rules put in place in 2001 that have since restricted clinical trial growth in their region early next week. In the past few years, the number of clinical trials in the region has dropped by 15%. Currently, those conducting clinical trials have to submit applications in each country they're conducting clinical research. That in addition to added costs and regulations have contributed to the decrease of clinical trials in the region. With the changing of these regulations, it will make it easier to conduct cross-border clinical trials, which is important for trials for rarer diseases.
This fall at Partnerships in Clinical Trials Asia professionals will gather to discuss Hurdling Obstacles in Going to Europe. For more information on this program, download the agenda. If you'd like to join us September 10-12, 2012 in Shanghai, as a reader of this blog when you register and mention code XP1777BLOG, you'll save 15% off the standard rate!
What do you think the regulations changing will mean for the future of clinical trails? Will more be conducted in Europe?
The Partnerships in Clinical Trials Blog focuses on optimization intelligence, regulatory trends and globalization strategies for both sponsors and CROs. It is supported by a number of industry events.
Would you like to guest blog on our site? Or send us feedback? Send an email to firstname.lastname@example.org.